Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-30 pm EST
46.03 USD   +0.33%
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
2022LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LeMaitre to Present at Upcoming Investor Conferences

11/02/2022 | 03:29pm EST

BURLINGTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.

David Roberts, President, will present at the Stifel Healthcare Conference on Tuesday, November 15, 2022 at the Lotte New York Palace in New York City. The company’s presentation is scheduled at 3:00 PM ET.

JJ Pellegrino, Chief Financial Officer, is scheduled to host a series of 1x1 meetings at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 17, 2022 at the Westin NY Grand Central Hotel in New York City.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com


Primary Logo

Source: LeMaitre Vascular, Inc.

2022 GlobeNewswire, Inc., source Press Releases

All news about LEMAITRE VASCULAR, INC.
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
2022LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and ..
AQ
2022Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 2..
CI
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022North American Morning Briefing: Futures Pull -3-
DJ
2022Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform
MT
2022Lemaitre : Q3 Earnings Snapshot
AQ
2022Transcript : LeMaitre Vascular, Inc., Q3 2022 Earnings Call, Oct 27, 2022
CI
2022LeMaitre Vascular, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
More news
Analyst Recommendations on LEMAITRE VASCULAR, INC.
More recommendations
Financials (USD)
Sales 2022 162 M - -
Net income 2022 20,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 49,5x
Yield 2022 1,09%
Capitalization 1 013 M 1 013 M -
Capi. / Sales 2022 6,26x
Capi. / Sales 2023 5,91x
Nbr of Employees 469
Free-Float 82,5%
Chart LEMAITRE VASCULAR, INC.
Duration : Period :
LeMaitre Vascular, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEMAITRE VASCULAR, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 46,03 $
Average target price 56,60 $
Spread / Average Target 23,0%
EPS Revisions
Managers and Directors
George W. LeMaitre Chairman & Chief Executive Officer
David B. Roberts Chief Financial Officer
Joseph P. Pellegrino Chief Financial Officer, Secretary & Director
Jonathan W. Ngau Director-Information Technology
Ryan H. Connelly Vice President-Research & Development